Contact
Name:
Please fill name field
E-mail:
Please fill email field
Phone:
Message:
Please enter the numbers:
Please enter the correct digits
Your message was sent successfully
Novetide's TevaTech peptide manufacturing site increases production capacity by more than 50%...
16 October, 2012
Novetide's TevaTech peptide manufacturing site increases production capacity by more than 50% and can now manufacture lot sizes up to 3 Kg. for even the most complicated peptides. Novetide's production sites are supported by sophisticated peptide-dedicated QC laboratories and experienced QC and QA teams. They are routinely inspected by the FDA and are compliant with regulatory requirements in the relevant target markets worldwide